UNITED STATES OMB APPROVAL
SECURITIES AND EXCHANGE COMMISSION  OMB Number: 3235-0101
Washington, D.C. 20549  Expires: June 30, 2020
   Estimated average burden
FORM 144  hours per response 1.00
NOTICE OF PROPOSED SALE OF SECURITIES SEC USE ONLY
PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933  DOCUMENT SEQUENCE NO.
   
   CUSIP NUMBER

ATTENTION: Transmit for filing 3 copies of this form concurrently with either placing an order with a broker to execute sale or executing a sale directly with a market maker.

 

   
 1 (a) NAME OF ISSUER (Please type or print)  (b) IRS IDENT. NO.  (c) S.E.C. FILE NO.  WORK LOCATION

 

Alector, Inc.

 462702363  001-38792  
 1 (d) ADDRESS OF ISSUER  STREET CITY STATE ZIP CODE  (e) TELEPHONE NO
          AREA CODE NUMBER
 131 Oyster Point Blvd, Suite 600    South San Francisco  CA 94080 415  231-5660
 2 (a) NAME OF PERSON FOR WHOSE ACCOUNT THE SECURITIES ARE TO BE SOLD    (b) RELATIONSHIP TO ISSUER (c) ADDRESS STREET CITY STATE ZIP CODE

 

OrbiMed Advisors LLC on behalf of OrbiMed Private Investments IV - AL (Feeder), LP

  Shareholder  c/o OrbiMed Advisors LLC
601 Lexington Avenue, 54th Floor
New York NY 10022
                   

 

INSTRUCTION: The person filing this notice should contact the issuer to obtain the I.R.S. Identification Number and the S.E.C. File Number.

 

3 (a) (b) SEC USE ONLY  (c)  (d)  (e)  (f)  (g)
Title of the Class of Securities To Be Sold Name and Address of Each Broker Through Whom the Securities are to be Offered or Each Market Maker who is Acquiring the Securities

Broker-Dealer

File Number

Number of Shares or Other Units To Be Sold Aggregate Market Value Number of Shares or Other Units Outstanding Approximate Date of Sale Name of Each Securities Exchange
      (See instr. 3(c)) (See instr. 3(d)) (See instr. 3(e)) (See instr. 3(f))
(MO. DAY YR.)
(See instr. 3(g))

Common

 

Morgan Stanley
1300 Thames Street
Thames Street Wharf, 3rd Floor
Baltimore, MD 21231

 

 

97,576

 

$2,280,355

 

78,992,871

 

4/9/2020

 

NASDAQ

 

 

 

 

 

 

 

 

 

 

 

 

INSTRUCTIONS:        
1. (a)  Name of issuer   3. (a)  Title of the class of securities to be sold
  (b) Issuer’s I.R.S. Identification Number     (b) Name and address of each broker through whom the securities are intended to be sold
  (c) Issuer’s S.E.C. file number, if any     (c) Number of shares or other units to be sold (if debt securities, give the aggregate face amount)
  (d) Issuer’s address, including zip code     (d) Aggregate market value of the securities to be sold as of a specified date within 10 days prior to filing of this notice
  (e) Issuer’s telephone number, including area code     (e) Number of shares or other units of the class outstanding, or if debt securities the face amount thereof outstanding, as shown by the most recent report or statement published by the issuer
          (f) Approximate date on which the securities are to be sold
2. (a) Name of person for whose account the securities are to be sold   (g) Name of each securities exchange, if any, on which the securities are intended to be sold
  (b) Such person’s relationship to the issuer (e.g., officer, director, 10% stockholder, or member of immediate family of any of the foregoing)      
  (c) Such person’s address, including zip code      
Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1147 (08-08)
               

 

TABLE I — SECURITIES TO BE SOLD

 

Furnish the following information with respect to the acquisition of the securities to be sold

and with respect to the payment of all or any part of the purchase price or other consideration therefor:

 

Title of

the Class

Date you

Acquired

Nature of Acquisition Transaction

Name of Person from Whom Acquired

(If gift, also give date donor acquired)

Amount of

Securities Acquired

Date of

Payment

Nature of Payment

Common Stock

 

 

More than 1 year

 

Private Placement

 

Issuer

 

97,576

 

More than 1 year

 

Cash

 

 

 

INSTRUCTIONS:   If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.
 

TABLE II — SECURITIES SOLD DURING THE PAST 3 MONTHS

 

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

 

Name and Address of Seller Title of Securities Sold Date of Sale

Amount of

Securities Sold

Gross Proceeds

OrbiMed Private Investments IV - AL (Feeder), LP
c/o OrbiMed Advisors LLC
601 Lexington Avenue, 54th Floor
New York, NY 10022

 

 

 

Common Stock

 

3/2/20

3/23/20

3/24/20

3/25/20

3/31/20

4/7/20

4/8/20

 

 

445,086

3,541

16,409

13,684

60,645

2,224

20,041

 

 

$11,572,980

$92,230

$401,166

$337,454

$1,485,856

$51,378

$473,996

 

 

REMARKS:

 

 

 

INSTRUCTIONS:   ATTENTION:
See the definition of “person” in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.   The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

 

 

  4-9-2020     /s/ Douglas Coon  
  DATE OF NOTICE     (SIGNATURE)  
        Douglas Coon
Chief Compliance Officer of OrbiMed Advisors LLC, Managing Member of the General Partner of OrbiMed Private Investments IV - AL (Feeder), LP
 
           
  DATE OF PLAN ADOPTION OR GIVING OF INSTRUCTION,
IF RELYING ON RULE 10B5-1
 

The notice shall be signed by the person for whose account the securities are to be sold. At least one

copy of the notice shall be manually signed. Any copies not manually signed shall bear typed or printed signatures.

 

 

ATTENTION:  Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

SEC 1147 (02-08)